EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS007-07537 
Organism
Homo sapiens 
Tissue/cell
BE2C 
Coordinate
chr17:80549180-80551930 
TF binding sites/motifs
Number: 19             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:80551231-80551249GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr17:80551235-80551253GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr17:80551250-80551268GGGAAAGAGGAAGGAAGG+6.14
EWSR1-FLI1MA0149.1chr17:80551254-80551272AAGAGGAAGGAAGGAAAG+6.23
EWSR1-FLI1MA0149.1chr17:80551239-80551257GGAGGGAGGGAGGGAAAG+6.31
EWSR1-FLI1MA0149.1chr17:80551258-80551276GGAAGGAAGGAAAGGAGA+6.82
EWSR1-FLI1MA0149.1chr17:80551227-80551245GGAAGGAGGGAGGGAGGG+7.12
EWSR1-FLI1MA0149.1chr17:80551223-80551241GGAAGGAAGGAGGGAGGG+7.97
EWSR1-FLI1MA0149.1chr17:80551219-80551237GGAAGGAAGGAAGGAGGG+9.72
KLF4MA0039.3chr17:80549241-80549252CCACACCCTGC+6.62
ZNF263MA0528.1chr17:80551255-80551276AGAGGAAGGAAGGAAAGGAGA+6.03
ZNF263MA0528.1chr17:80551256-80551277GAGGAAGGAAGGAAAGGAGAG+6.18
ZNF263MA0528.1chr17:80551244-80551265GAGGGAGGGAAAGAGGAAGGA+6.66
ZNF263MA0528.1chr17:80551220-80551241GAAGGAAGGAAGGAGGGAGGG+6.96
ZNF263MA0528.1chr17:80551236-80551257GAGGGAGGGAGGGAGGGAAAG+7.12
ZNF263MA0528.1chr17:80551224-80551245GAAGGAAGGAGGGAGGGAGGG+7.6
ZNF263MA0528.1chr17:80551240-80551261GAGGGAGGGAGGGAAAGAGGA+7.81
ZNF263MA0528.1chr17:80551232-80551253GAGGGAGGGAGGGAGGGAGGG+7.97
ZNF263MA0528.1chr17:80551228-80551249GAAGGAGGGAGGGAGGGAGGG+8.94
Number of super-enhancer constituents: 7             
IDCoordinateTissue/cell
SE_01005chr17:80548616-80552104Adrenal_Gland
SE_08753chr17:80547611-80552483Brain_Inferior_Temporal_Lobe
SE_23457chr17:80549045-80550903Colon_Crypt_1
SE_23457chr17:80551075-80552168Colon_Crypt_1
SE_24526chr17:80549996-80550760Colon_Crypt_2
SE_24526chr17:80551131-80552073Colon_Crypt_2
SE_31768chr17:80548538-80552181Gastric
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr178054944680549833
Enhancer Sequence
GAGCCCATCC CTGGCCTGTC AGGTTCACCA GGGTGGCCCC TGGTCCCGTT GTCGCCGTTG 60
TCCACACCCT GCCCACCTGC CAATGCTCCT GTGTCCCCTG CTCTGCTCCA GGGCCCCAAA 120
CCCTGTGCAG AGCTGGGGTG CATCATGCTG CCGCCCCATG GAGAAGGCCT GGAGGAGATG 180
GAAGCCGGGA GGCTTCCTCT TACAGGAAGG GAAGCCCCAG AAATGTGCCT GGCACCAAGA 240
AACTGCTCCA AGCTTGTTCC AGAGTGTGGG GAGGGCTTGA GGCCTCCCCT TTTTGAGTAC 300
ATGGAAAGGA AAGCCTGGCA TTTTCTGGAA ACGCTCCCAA GTCTCCCTGG CAGGGAGATG 360
TGGGAAGAGT CCAGGCGCCC AAGCTCTTGC ATATTCACTT CCTCCCATCA CACGTGCTGT 420
GTACAAGCAC CCTCAGAGCT CGCTTTGGGA GACCCCTGCC TCAGGGCTGC GGGTGCCGCC 480
GTCCACACCA CAGGCCCTTC TGCTTCCTGT TTCCAAAGCT CATCTCCTGT CTCTGGGCTG 540
CAGGCGCTGT TTCTGGTTTA CTGGCACAAC TGTGGTTGTG TTTTTGTCAA TGACTTCATC 600
TTTGCTGCTG TTGTTTTGAG ATACTGTCTT GCTCTGTCAC CCAGGCTGGA GTGCAGTGCC 660
GAGATCTCAA CTCACTGCAG CCCCGACCTA CTGGTCTCAA GCCATCCTCC TGCCTCAGCC 720
TCCCAAGTAG CTGGGACTAC AGGTGTGCAG CACCACATCC AGCTAAGTTT TTGTATTTTT 780
TGTAGAGACA GGGTCTCACT ATGTTGCCCA GGCTGGTTTC AAACTCCTGG ACTCTGGTGA 840
TCCTCTAGCC TTGGCCTCCC AAAGTGCTGG GATTACAGGT ACGAGCCAGC ATACCCAGCC 900
AGTGTTGTCG TTTTGATTTG GGAGTTCGGG GCTGAGCTGT GTTTGGCCAG GGCCTCGCCT 960
GCTCAGTGTG CTCCTGGGCT GAGCTGCGGT CCTGGAGCAT CTCTTGGCTC ACATATTGAC 1020
TCCTCCGGCC TCTCTACTGT CCTGGTCCTT CATGGGGCTC ACATGTGTGT CCTCTTGTTT 1080
TCTTTCTGTC ACCTTCTTAA GGGTTCACAG ATCACTGTCA GTGGAAGGTG TTGCCACAGC 1140
TCAAGCCTCA CAGTGGAGGA ACCTCATGAG GCCCTTCACG GGGCCACTCC CTGTCTGGAC 1200
AGGCCTGCCT GACCAGCCCT GCTGGGAAGC CTGGGCTTTG CTGCTGCTTC ACCCTGCGAC 1260
ATTCTCCTCA GGCCCTGCCT TTCGCTTCTT TCGTTAACAT TGTTCCTGCC TTGATCGTTT 1320
GCTCCCTCCT GCCTAACTCT GCTCTTCTTC CTTGTGTAGC AGTTACGTGG TCCTCAAATA 1380
TCATTTGTTG ACTCCAGTGT TTCCTGGGGC ATCTCCTCAA GCTGGCTGGG GTTCTCTGCA 1440
TCTCAGCTGT GGCGCCTGGT GTGAGGGCGC ACGCTTCGCA GTGAGAGTGA AATGCCCAGT 1500
TCGCGCTGGC AGAGGGAGAC CCTGTGAAGG TCTCCCTGTG CCAGGCACAG GCTCTTATTC 1560
TGAAAGCAGA CCCCGTGAAG GTCTCCCTGT GCCGGGCACA GGCTCTTATT CTGAAAGTAG 1620
ACCCTGTGAA GGTCTCCCTG CGCCGGGCAC AGGCTCTTAT TCTGAAAGCA GACCCAGTGA 1680
AGGTCTCCCT GTACCGGGCA GAGGCTCTTA TTCTGAAAGC AGACCCCGTG AAGGTCTTCC 1740
TGTACCGGGC ACAGGCTCTT ATTCTGAAAG ACCCAGTGAA GGTCTCCCTG CGCCGGGCAC 1800
AGGCTCTTAT TCTGAAAGCA GACCCCGTGA AGGTCTCCCT GCACCGGGCA CAGGCTCTTA 1860
TTCTGAAAGC AGACCCAGTG AAGGTCTCCC TGTGCCAGGC AGAGGCTCTT ATTCTGAAAG 1920
CAGACCCAGT GAAGGTCTCC CTGTGCCAGG CAGAGGCTCT TATTCTGAAA GCAGACCCTG 1980
TGAAGGTCTC CCTGTACCGG GCACAGGCTC TTATTCTGAA AGGGTACGCA GCAGTTTCTG 2040
GAAGGAAGGA AGGAGGGAGG GAGGGAGGGA GGGAAAGAGG AAGGAAGGAA AGGAGAGCGA 2100
TAGGCACAGA GGAAGGTAGA TGAAGCCCCG CGCCCCCCTG GCGGAGCCCA GCCCTGTTCA 2160
CCGCGTGCTG TGCGGGTGCC TGTGCCAGGA TCAGCTGGCT GGACGGCTAT AGCCCCACGC 2220
CTGCAGGCCA CATACCTGGG AGAGTGTGGG CCTTCCGAGC CTTCTGGCTC CCGGCCCCAC 2280
AGAGGAATTA CGGTCCCATG TCCCTCACAA GGACCCTTGC AGAGGGAGCA GTGCATCGGC 2340
ACAGAGCAGG ACACAGGGGA GCCGGGCTGA GGCTGCGGGT CCCTTGTGGC CGCCAGGTGC 2400
TCACGCGTGC CTCGGTGGGG ATCTGGCAGC CAGATTTGGG GTGAGGATTT GATGATGTGG 2460
GTATCCCTAG CTGGTCCCAC AGTGACGATG GGTGTTGCGT TGTGAGCATG TAAAACGGCA 2520
GTGACGTCTG AGGGTCCCTG GACGTCTTTC ACACCCAGCC TCAAAGCGGA GCCTTTCCAG 2580
GCAGAGCAGC AGCTGCCGCC ACTGGATTGA CAGCCCCAGA GCAGCGGGAT CAGGCCACGC 2640
GGACGAGGAG GTGCGAGGCC TCGGGTCGGG GCCTGTGTTC TGCGGGAGCC GCACCCATCA 2700
TCGCTGTGGC GGTGGCAGTG GAGCAGCTGC TCTCGTGTCT GAGCTGCTCC 2750